Safety and Usability of the Inga Catheter for Labor Induction (INGA-MDP)

Recruiting now · Not applicable

Conditions studied: Induction of Labor, Cervical Ripening, Cervical Ripening and Induction of Labor

In brief

The goal of this clinical study is to evaluate a new mechanical balloon catheter (INGA) used to prepare the cervix for labor induction in pregnant women at term. The study aims to assess the safety, usability, and performance of the INGA catheter when used for cervical ripening before labor. Researchers will also collect feedback from healthcare professionals and participants about the use of the device. Participants are pregnant women at term with a single baby in a head-down position who meet the study eligibility criteria. Participants will: * have the INGA balloon catheter inserted as part of labor induction, * receive standard clinical care according to hospital practice, * provide information about their experience and outcomes related to the device. The results of this study will help determine whether the INGA catheter is safe and suitable for use in cervical ripening during labor induction.

Key facts

Study ID

NCT07414771

Run by

Aalto University

People needed

45

Starts

2026-07-01

Expected to finish

2027-03-31

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older, up to 56. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant women aged ≥18 and ≤56 years
• An unripe cervix, ≤6 points according to the Bishop assessment (0-10 point scale)
• Planned induction of labor by mechanical balloon catheter method
• Examples of diagnoses as the basis for labor induction:
• Post-term pregnancy (≥41 weeks of gestation)
• Maternal request for labor induction
• Gestational diabetes
• Preeclampsia (with blood pressure <150/100)
• Well-controlled hypertension
• Cholestasis of pregnancy
• Humanitarian or psychosocial reasons
• Gestational age at the time of the study ≥ 37 weeks (gestational age confirmed by ultrasound before the 21st week of pregnancy)
• Singleton pregnancy
• Cephalic presentation
• The subject understands the study information and signs the consent form

You may not qualify if…

• Preterm induction of labor (<37 weeks of gestation)
• Pathological CTG at inclusion
• Spontaneous rupture of membranes at inclusion
• Clinically significant vaginal bleeding with need of hospitalization in the third trimester
• Clinically active vaginal or uterine infection
• Maternal HIV, hepatitis C, or hepatitis B
• Uterine scar (including previous cesarean section)
• Condition of the fetus or mother requiring immediate delivery
• Presence of eclampsia
• Severe Pre-eclampsia (Blood pressure ≥160/110 and any of the following: low platelet count (<100 × 10 9/L), HELLP, progressive renal insufficiency, pulmonary edema)
• Severe fetal growth restriction (FGR, fetal growth < -2 SD)
• Estimated fetal weight ≥ 2SD or ≥ 95th percentile
• Breech or transverse fetal position
• Multiple pregnancy
• Vasa previa or placenta previa
• Umbilical cord prolapse
• Maternal refusal to participate in the study and/or insufficient language skills to understand the study information and/or consent form

Where it is running

• Helsinki University Hospital — Helsinki, HUS, Finland (enrolling)
• Hospital Nova — Jyväskylä, Finland (enrolling)
• Tampere University Hospital — Tampere, Finland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.